Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Epidemiology. 2021 Mar 1;32(2):282–290. doi: 10.1097/EDE.0000000000001319

Table 1.

Allowability Designations of Estimators

A1y A1m N1
1. Oaxaca–Blinder Decomposition via Linear Models52,53: All covariates are considered non-allowable X0age,X0sex,X0edu,X0ins,X0dia,L1
2. Oaxaca–Blinder Decomposition Estimator via Reweighting Functions: No covariates considered outcome-allowable; all covariates are considered target-allowable38,39 X0age,X0sex,X0edu,X0ins,X0dia,L1
3. Natural Direct/Indirect Effect Analogue Estimators33,4143,48,5658: All covariates are considered outcome- and target-allowable X0age,X0sex,X0edu,X0ins,X0dia,L1
4. Path-Specific Effect Analogue (I & II) Estimator5,36,46: Demographic covariates considered outcome- and target-allowable; remaining covariates considered non-allowable X0age,X0sex X0edu,X0ins,X0dia,L1
5. Path-Specific Effect Analogue (III) Estimator44,47: Demographic covariates outcome- and target-allowable; remaining covariates considered target-allowable X0age,X0sex X0edu,X0ins,X0dia,L1
6. A Meaningful Estimator: Demographic covariates considered outcome- and target-allowable; clinical covariates considered target-allowable; socioeconomic covariates considered non-allowable X0age,X0sex X0dia,L1 X0edu,X0ins

Abbreviations: A1y outcome- (and target-) allowable covariates, A1m exclusively target-allowable covariates, N1 non-allowable covariates, the empty set; List of covariates include Xage age, Xsex sex, Xedu educational attainment, Xins private health insurance, Xdia diabetes, L1 baseline blood pressure